RESUMO
A pandemic of staphylococcal infections occurred in the mid-twentieth century and spanned the years from about 1946 (with gradual subsidence) to about 1966. Staphylococcus aureus, originally sensitive to penicillin in 1942, demonstrated, more than other susceptible bacteria, a capacity for the development of antibiotic resistance. Hospital personnel became carriers of antibiotic-resistant staphylococci that contaminated newborn infants and hospitalized children and adults, who then became carriers and suffered an increasing incidence of suppurative disease. Asymptomatic carriers of antibiotic-resistant epidemic strains spread them into communities, with resulting infection of others. Newer antibiotics were developed, only to lose effectiveness as the staphylococci developed resistance. Local, national, and international programs emerged for the development of epidemiologic research, hospital surveillance, and education in methods of prevention and control. Carrier rates of S. aureus among hospital personnel remained approximately 33%, while the incidence of nosocomial staphylococcal infections declined. Staphylococcal pandemics may be cyclic in occurrence.
Assuntos
Controle de Doenças Transmissíveis/história , Infecção Hospitalar/história , Surtos de Doenças/história , Infecções Estafilocócicas/história , Infecção Hospitalar/epidemiologia , História do Século XX , Infecções Estafilocócicas/epidemiologia , Estados Unidos/epidemiologiaRESUMO
The synthesis of 6-bromo-1-ethyl-2,4-dioxo-1,2,3,4-tetrahydroquinazoline, its benzoyl and its benzyl derivatives is described. The unreported 5-bromo-N-phenyl-anthranilic acid was synthesized from anthranilic acid adopting a procedure, which involved a novel synthesis of 2,5-dibromobenzoic acid. Direct bromination of N-phenylanthranilic acid and N-p-tolyl-anthranilic acid afforded the tribromo-and dibromoderivatives respectively.
